Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation

Revital Ben Aziz-Aloya, Ditsa Levanon, Heather Karn, Debora Kidron, Dalia Goldenberg, Joseph Lotem, Sylvie Polak-Chaklon, Yoram Groner

Research output: Contribution to journalArticlepeer-review

Abstract

The human AML1 gene encodes a heterodimeric transcription factor which plays an important role in mammalian hematopoiesis. Several alternatively spliced AML1 mRNA species were identified, some of which encode short protein products that lack the transactivation domain. When transfected into cells these short isoforms dominantly suppress transactivation mediated by the full length AML1 protein. However, their biological function remains obscure. To investigate the role of these short species in cell proliferation and differentiation we generated embryonic stem (ES) cells overexpressing one of the short isoforms, AML1-d, as well as cells expressing the full length isoforms AML1-b and AML2. The in vitro growth rate and differentiation of the transfected ES cells were unchanged. However, overexpression of AML1-d significantly affected the ES cells' ability to form teratocarcinomas in vivo in syngeneic mice, while a similar overexpression of AML1-b and AML2 had no effect on tumor formation. Histological analysis revealed that the AML1-d derived tumors were poorly differentiated and contained numerous apoptotic cells. These data highlight the pleiotropic effects of AML1 gene products and demonstrate for the first time an in vivo growth regulation function for the short isoform AML1-d.

Original languageEnglish
Pages (from-to)765-773
Number of pages9
JournalCell Death and Differentiation
Volume5
Issue number9
DOIs
StatePublished - Sep 1998
Externally publishedYes

Keywords

  • AML1 short isoform
  • Altered in vivo differentiation
  • ES cells induced teratocarcinomas
  • Enhanced apoptosis

Fingerprint

Dive into the research topics of 'Expression of AML1-d, a short human AML1 isoform, in embryonic stem cells suppresses in vivo tumor growth and differentiation'. Together they form a unique fingerprint.

Cite this